Eiken Chemical Co., Ltd.
Eiken Chemical Co., Ltd. Financial Summary for the Second Quarter (Interim) of the Fiscal Year Ending March 2027
For the second quarter, net sales were 21,388 million yen, up 4.7% year-over-year; operating income was 1,587 million yen, down -8.2%; ordinary income was 1,616 million yen, down -6.6%; and interim net income attributable to owners of parent was 1,125 million yen, down -62.2%. Full-year forecasts remain unchanged from the previous announcement. No information on share buybacks is provided. Dividends are maintained at 29 yen at the end of the second quarter, unchanged from the prior year, with a full-year forecast of 58 yen. Financial position: total assets 64,023 million yen, net assets 44,247 million yen, and equity ratio 69.1%. Major asset and liability breakdowns are disclosed.
Key Figures
- Net Sales: 21,388 million yen (Year-over-Year +4.7%)
- Operating Income: 1,587 million yen (Year-over-Year -8.2%)
- Net Income Attributable to Owners of Parent (Interim): 1,125 million yen (Year-over-Year -62.2%)
AI要約
Overview of Results
Net sales for the interim period were 21,388 million yen (YoY +4.7%), securing revenue growth. Meanwhile, operating income was 1,587 million yen (YoY -8.2%) and ordinary income was 1,616 million yen (YoY -6.6%), reflecting a decline due to the impact of one-off special income in the prior-year period and changes in business composition. Interim net income attributable to owners of parent was 1,125 million yen (YoY -62.2%), a substantial decrease. There have been no major revisions to the initial forecasts, and the full-year projections remain unchanged. Financial soundness is maintained with total assets of 64,023 million yen, net assets of 44,247 million yen, and an equity ratio of 69.1%.
Dividends, Capital Policy and Outlook
Annual dividend is expected to remain at 29 yen at the second quarter-end and 58 yen for the full year. The financial summary is presented as a "financial" report, and no changes to dividend policy have been announced. Earnings forecasts remain as previously disclosed; while there is room for short-term improvement in profitability, the long-term strategy focusing on areas such as "contribution to cancer prevention and treatment" toward 2030 will continue.
Net Sales Trend
Operating Income Trend
Interim Net Income Attributable to Owners of Parent Trend
Assets Composition
Liabilities Composition
Dividend Policy Trend
Eiken Chemical Co., Ltd.
Company overview · Stock price · Financial data · All IR
